The Drugs Controller General of India (DCGI) has again found Sanofi's popular painkiller drug, Combiflam, of 'sub-standard' quality, in its latest test last month. It had found the same defect in the medicine in February and April, too. "We are ... Business Standard India, 1 month ago
No pain relief for Combiflam - Business Standard, 1 month ago
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, as you know, our treasured signal to daydream about weekend plans. And our agenda is rather modest. We plan to spend time with two of our short people and ...StatNews.com, 1 month ago
This would ensure that the drugs available are not sub-standard Bar coding for medicines, training for drug manufacturers and an integrated approach toward zero tolerance for sub-standard medicines in the country is on the anvil. All this has ...The Hindu, 1 month ago
In an effort to counter the over-charging of medicines and sale of spurious drugs,India is all set to introduce a unique identification code system. The country's drug regulatory authority, the Drug Controller General of India (DCGI), recently ...International Business Times India, 2 months ago
on your WebpageAdd Widget >Get your members hooked!